Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrospective study of therapeutic drug monitoring for tobramycin in cystic fibrosis
NL-OMON20263Active, not recruiting
- Sponsor
- AMC Health
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tobramycin in cystic fibrosis (CF) and Pseudomonal infection, sponsored by AMC Health. Primary endpoint: Plasma tobramycin levels within the target range. Started May 2014; status: active, not recruiting.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)Pseudomonal infection
Beyond the preview
Go deeper on NL-OMON20263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20263.